AUROPHARMA.NS Financials

Financials

Trends

* Timeframes marked with (Est.) are analyst estimates based on consensus data.

Details

Breakdown	2026	2025	Change %
Total Revenue	333.847.400.000	313.781.300.000	6.4%
Cost of Revenue	143.249.300.000	137.415.200.000	4.2%
Gross Profit	190.598.100.000	176.366.100.000	8.1%
	138.669.400.000	125.885.500.000	10.2%
Operating Income	51.928.700.000	50.480.600.000	2.9%
Pretax Income	51.118.500.000	50.662.900.000	0.9%
Net Income Common Stockholders	35.047.500.000	34.858.800.000	0.5%
	--	--	--
	--	--	--